Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $8092.2.

  • Addex Therapeutics' Other Non-Current Assets fell 8679.14% to $8092.2 in Q4 2024 from the same period last year, while for Dec 2024 it was $8092.2, marking a year-over-year decrease of 8679.14%. This contributed to the annual value of $8058.1 for FY2024, which is 8668.28% down from last year.
  • Latest data reveals that Addex Therapeutics reported Other Non-Current Assets of $8092.2 as of Q4 2024, which was down 8679.14% from $904951.6 recorded in Q1 2024.
  • Over the past 5 years, Addex Therapeutics' Other Non-Current Assets peaked at $904951.6 during Q1 2024, and registered a low of $8092.2 during Q4 2024.
  • Its 3-year average for Other Non-Current Assets is $257682.6, with a median of $58843.3 in 2022.
  • Per our database at Business Quant, Addex Therapeutics' Other Non-Current Assets skyrocketed by 858.41% in 2023 and then tumbled by 8679.14% in 2024.
  • Over the past 3 years, Addex Therapeutics' Other Non-Current Assets (Quarter) stood at $56421.7 in 2022, then grew by 8.58% to $61265.0 in 2023, then crashed by 86.79% to $8092.2 in 2024.
  • Its last three reported values are $8092.2 in Q4 2024, $904951.6 for Q1 2024, and $61265.0 during Q4 2023.